Your session is about to expire
← Back to Search
Non-Contact Sleep Monitor for Alzheimer's Disease
N/A
Waitlist Available
Led By Kathleen Unroe, MD, MHA, MS
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of Alzheimer's Disease (AD) or Alzheimer's Disease Related Dementias (ADRD)
Be older than 18 years old
Must not have
Currently on hospice
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if access to sleep quality data helps detect/treat sleep disturbances in people with Alzheimer's, leading to better sleep and less daytime physical inactivity.
Who is the study for?
This trial is for long-term care residents with Alzheimer's or related dementias who've been at the facility for at least 30 days. Participants can join themselves or through a legal rep if they can't make decisions. It's not open to those on hospice.
What is being tested?
The study tests a Non-Contact Sleep Quality Monitor System in monitoring sleep quality of individuals with Alzheimer's in long-term care. The impact of sharing real-time sleep data with caregivers on detecting and treating sleep disturbances is evaluated.
What are the potential side effects?
Since this trial involves non-contact monitoring, there are no direct side effects from the intervention itself. However, changes in treatment based on data may have their own effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Alzheimer's Disease or a related dementia.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently receiving hospice care.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Documentation of sleep disorders or treatment
Secondary study objectives
Attitudes Toward Technology
Change in Epworth Sleepiness Scale Total Score Over Time
Change in QOL-AD Over Time
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Long-Term Care Facility Residents with Alzheimer's Disease or other Related DementiasExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,793 Previous Clinical Trials
28,192,032 Total Patients Enrolled
Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,219,964 Total Patients Enrolled
Innovative Design LabsUNKNOWN
1 Previous Clinical Trials
119 Total Patients Enrolled
Regenstrief Institute, Inc.OTHER
26 Previous Clinical Trials
98,417 Total Patients Enrolled
Mayo ClinicOTHER
3,353 Previous Clinical Trials
3,060,923 Total Patients Enrolled
University of MinnesotaOTHER
1,436 Previous Clinical Trials
1,621,583 Total Patients Enrolled
Kathleen Unroe, MD, MHA, MSPrincipal InvestigatorIndiana University School of Medicine